-transparent.png){kind=logo}
In an open therapeutic trial, 50 patients with acne vulgaris were randomly allocated to one of two groups. One group received spironolactone 100 mg daily and the other cimetidine 1.6 g daily for 12 weeks. Clinical severity of acne and sebum excretion decreased significantly at the end of the trial with both drugs, but significantly more with spironolactone. Mean serum levels of testosterone, androstenedione and dehydroepiandrosterone-sulfate decreased significantly with spironolactone but showed no change with cimetidine. Our data suggest that spironolactone may be useful as antiandrogen in the short term therapy of acne vulgaris.
Related Publications
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
August 1986,
Zeitschrift fur Hautkrankheiten,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
November 1987,
La Clinica terapeutica,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
November 1983,
Presse medicale (Paris, France : 1983),
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
January 2015,
Dermatologic therapy,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
July 1987,
La Clinica terapeutica,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
August 1979,
Lancet (London, England),
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
January 1982,
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
November 1987,
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
January 1982,
Journal of the American Academy of Dermatology,
A Hatwal, and
R P Bhatt, and
J K Agrawal, and
G Singh, and
H S Bajpai
January 1988,
The Australasian journal of dermatology,
